Background. The purpose of our study was to evaluate the maternal cardiopulmonary function and lung water content during percutaneous fetoscopic interventions under general maternal -fetal anaesthesia and continuous tocolytic medication.
The life-threatening consequence of a spectrum of fetal malformations has prompted efforts to assess the feasibility of minimally invasive fetoscopic fetal surgical interventions. During more than 200 studies in sheep performed by members of our own group, fetoscopic techniques for safe and reproducible percutaneous intra-amniotic access, partial amniotic carbon dioxide insufflation, fetal posturing, fetal transoesophageal echocardiography, and percutaneous uterine closure were developed in order to achieve or facilitate direct fetal cardiac access, patch coverage of the exposed neural tissue in fetuses with spina bifida aperta, temporary tracheal occlusion in fetuses with diaphragmatic hernia, release of amniotic bands, and tracheal decompression in fetuses with congenital high airway obstruction syndrome. 1 2 At the time of the clinical introduction of these minimally invasive fetoscopic techniques at our centre about 6.5 yr ago, 3 maternal pulmonary oedema had been one of the most feared problems. In an analysis by the pioneering San Francisco group, this complication was observed in about one-fourth of women regardless whether an open surgical or less invasive fetoscopic approach was used. 4 At our institution, we observed a case of maternal pulmonary oedema after our first attempt at fetoscopic patch coverage of spina bifida aperta. 5 Although the anaesthetic and tocolytic regimen for fetal surgery may promote maternal pulmonary oedema, the mechanisms of fluid accumulation in the maternal lungs have not been completely understood. 6 Therefore, a systematic approach to determine the lung water content and pulmonary vascular permeability in pregnant women during fetal interventions would provide important, clinically relevant information.
We prospectively determined maternal systemic and pulmonary vascular haemodynamics, pulmonary water content, and pulmonary vascular permeability in midgestational women undergoing percutaneous fetoscopic interventions under general maternal -fetal anaesthesia. Haemodynamic monitoring consisted of pulmonary artery catheterization and the transpulmonary indicator dilution method to determine cardiac output, pulmonary vascular pressures, intrathoracic blood volume (ITBV), and extravascular lung water (EVLW).
Methods
After approval by the local committee on human research and in accordance with the ethical standards for human experimentation established by the Declaration of Helsinki, written informed consent was obtained from all patients. We prospectively studied 13 pregnant women between 19 and 30 weeks of gestation undergoing percutaneous fetoscopic procedures (Table 1) .
One hour before the procedure, all women received indomethacin 100 mg rectally for tocolysis and ranitidine 150 mg orally as acid aspiration prophylaxis. Before induction of anaesthesia, sedating drugs were not administered in order to avoid immobilization of the fetus before a favourable fetal position was observed. Rapid sequence induction of anaesthesia was performed using i.v. remifentanil (1 mg kg ). Balanced maternal -fetal anaesthesia was maintained with remifentanil, and desflurane in oxygen. Mechanical ventilation was provided with a standard anaesthetic machine (Julian, Dräger Incorporation, Lübeck, Germany). PEEP was set at 5 cm H 2 O and peak inspiratory pressure was adjusted to the value corresponding to a tidal volume of 6 ml kg 21 
.
The inspiratory-to-expiratory time ratio was set to 1:1 and the ventilator rate was adjusted to maintain a maternal arterial carbon dioxide tension between 30 and 40 mm Hg.
Ventilatory and gas-exchange data including tidal volume, minute ventilation, end-expiratory pressure and peak inspiratory pressure, inspired and expired concentrations of oxygen and desflurane, capnography, and pulse oximetry were taken from the anaesthetic machine and stored on a computer at sampling intervals of 5 s. Arterial and mixed venous blood gases, haemoglobin, and pH were determined with a standard blood gas analyzer (ABL 510, Radiometer, Copenhagen, Denmark).
Advanced haemodynamic monitoring was performed using a 7.5 F pulmonary artery catheter (Arrow AH-05050-PU, Reading, CA, USA) which was inserted through the right internal jugular vein, and a 4 F thermistor-tipped artery catheter (Pulsiocath PV2024-4F, Pulsion Medical Systems, Munich, Germany) which was advanced via the femoral artery into the descending aorta. Mean arterial pressure, central venous pressure, and mean pulmonary artery pressure were transduced continuously (Combitrans w , Braun AG, Melsungen, Germany), recorded (CS/3, Datex-Engström, Helsinki, Finland), and stored on a personal computer at sampling intervals of 5 s. Pulmonary artery occlusion pressure was measured intermittently.
The transpulmonary indicator dilution method was used to estimate cardiac output, ITBV, and EVLW. 7 8 In brief, 15 ml iced saline was used as an indicator and injected into the right cardiac atrium. The dilution curve of the indicator was recorded in the aorta with the thermistortipped artery catheter and a bedside computer (PiCCO, Pulsion Medical Systems) estimated cardiac output, ITBV, and EVLW. 9 10 Pulmonary vascular permeability was Remifentanil infusion and concentration of desflurane were adjusted to maternal and fetal analgesic and hypnotic requirements and a degree of uterine relaxation that would allow to technically execute the procedures and prevent contractions. Adequacy of maternal anaesthesia was judged by the bispectral index (target value 40 -50), fetal anaesthesia was judged adequate if there were no fetal movements and heart rate increases after painful stimuli and adequacy of uterine relaxation was judged clinically and by tocography.
Measurements of cardiovascular, ventilatory, and gas-exchange variables were started after induction of anaesthesia and insertion of catheters and continued during the first 24 postoperative hours in the ICU. Lactated Ringer's solution was infused at a rate of 4 ml kg 21 h
21
. In the case of haemodynamic instability (more than 20% reduction of mean arterial pressure when compared with the pre-anaesthetic period or a reduction of mean arterial pressure or cardiac output below 65 mm Hg or 3 litre min 21 m
22
, respectively), a rapid infusion of 250 ml of hydroxyethyl starch 6% was allowed under close control of ITBV and EVLW. If hypovolaemia was ruled out (ITBV above 850 ml m Immediately after the intervention, extubation was planned in the case of stable cardiopulmonary status. During the first postoperative day, tocolysis using indomethacin was continued and lactated Ringer's solution was infused at a rate of 120 ml h
21
. Postoperative opioid analgesia was provided with bolus doses of piritramide (0.03 mg kg
) as clinically needed. In order to detect and attend potential maternal and fetal complications, patients were monitored in the ICU during the first postoperative day.
Data were expressed as mean (SD) and evaluated for normal distribution with the Shapiro -Wilks W test. The data obtained during the intervention and the first postoperative day, respectively, were compared using the paired Student's t-test. Correlations were calculated between EVLW and cardiac output, mean pulmonary artery and pulmonary artery occlusion pressure, and ITBV using linear regression analysis. Differences were considered to be statistically significant if P0.05.
Results
The mean duration of the interventions was 152 min (range 60-645 min). Adequate transplacental fetal anaesthesia was achieved in all procedures as indicated by the absence of fetal movements and heart rate increases after painful stimuli.
During the intervention, mechanical ventilation with a PEEP of 5 (1) cm H 2 O and a peak inspiratory pressure of 19 (3) cm H 2 O resulted in a tidal volume of 7 (1) ml kg 21 , a minute ventilation of 78 (8) ml kg 21 min
21
, and an endtidal partial pressure of carbon dioxide of 34 (2) mm Hg.
Maternal heart rate (P,0.05) and cardiac output (P,0.01) were reduced during the intervention when compared with the postoperative period, whereas stroke volume and ITBV remained unchanged throughout the study (Table 2) . Mean pulmonary artery, central venous pressure, and pulmonary artery occlusion pressure increased (P,0.01), and mean arterial pressure decreased during the interventions (P,0.05). Intraoperatively, 1654 (591) ml of crystalloid infusions and 500 (299) ml of colloid infusions were given i.v. In one case, epinephrine (0.03-0.07 mg kg 21 min
) was infused for 45 min to keep cardiac output above 3.0 litre min 21 m 22 after hypovolaemia had been excluded. After the interventions, no colloids were infused. Mean urinary flow rates were 68 (43) ml h 21 during and 173 (42) ml h 21 after the interventions. Pulmonary gas exchange and haemodynamic parameters including cardiac output, ITBV and mean pulmonary arterial pressure, pulmonary arterial occlusion pressure, and central venous pressure were within the normal range during general anaesthesia and mechanical ventilation. All women were extubated immediately after the procedure. When compared with the intraoperative period, cardiac output and oxygen delivery and consumption increased and mean pulmonary arterial pressure, pulmonary arterial occlusion pressure, and central venous pressure decreased after the interventions (P,0.01) ( Table 2) . Although clinically overt pulmonary oedema and impairment of oxygenation were not observed in any of the patients, EVLW and pulmonary vascular permeability were above the normal range (Table 2 ). There was no significant correlation between EVLW and cardiac output (r 
Discussion
The purpose of our prospective study was to evaluate the maternal cardiopulmonary function and lung water content in mid-gestational women undergoing percutaneous fetoscopic interventions under general maternal -fetal anaesthesia and continuous tocolytic medication. Whereas the shortest procedures took about 60 min, an exceptional case of a very large thoraco-lumbo-sacral spina bifida aperta required 10.5 h for waterproof coverage in several layers. Maternal haemodynamics and pulmonary gas exchange remained stable during and after the interventions. However, a moderate increase in EVLW and pulmonary vascular permeability indicates an increased risk for maternal pulmonary oedema in these patients undergoing percutaneous fetal interventions.
Maternal pulmonary oedema has been shown to be a major problem during fetal interventions 4 15 16 occurring in about one-fourth of women regardless of whether an open surgical or less invasive fetoscopic approach was used. 4 Before the series of patients reported, we also observed one case of maternal pulmonary oedema after our first attempt at fetoscopic patch coverage of spina bifida aperta. 5 Although the anaesthetic and tocolytic regimen for fetal surgery may promote maternal pulmonary oedema, the mechanisms of fluid accumulation in the maternal lungs have not been completely understood. 6 During fetoscopic interventions, significant amounts of fluids can be absorbed into the maternal circulation and, consequently, may induce maternal fluid overload, if continuous amniotic fluid exchange with crystalloid solutions is used for uterine distension in order to improve visualization. Therefore, current treatment strategies for fetal interventions include maternal fluid restriction to avoid any impairment of pulmonary gas exchange. 4 15 16 However, volume depletion may impair maternal systemic blood flow and as a consequence promote the risk of uterine hypoperfusion perioperatively. 17 Therefore, balancing the benefits and the risks of fluid restriction is a challenge in fetal interventions.
We for the first time systematically investigated the maternal lung water content and cardiovascular status using invasive haemodynamic monitoring in midgestational women under continuous tocolytic medication who were undergoing fetal interventions under general anaesthesia. In the awake state, during the first postoperative day, systemic and pulmonary vascular blood pressures were normal and cardiac output was within the upper normal range which confirms the previous findings of a hyperdynamic cardiovascular status in normal pregnancy. 18 During anaesthesia, maternal haemodynamics were within normal ranges, as well. However, systemic arterial pressure and cardiac output were significantly reduced when compared with the awake state. At the same time, the reduction in cardiac output resulted in an overall decrease in oxygen delivery. Since oxygen consumption also decreased and oxygen extraction remained unchanged indicating a markedly reduced oxygen demand, we suggest that this was most likely caused by a reduced metabolic rate during anaesthesia. Similarly, the reduced cardiac output was mainly caused by a lowered heart rate that coincided with the infusion of remifentanil. In one case, heart rate reduction lowered cardiac output below 3.0 litre min 21 m 22 and therefore, in the absence of hypovolaemia, was treated with a low dose infusion of epinephrine to stabilize maternal systemic and uteroplacental blood flow. However, stroke volume remained constant in all women indicating no detrimental effects on maternal myocardial function. In agreement with these results, remifentanil did not produce further cardiovascular depression in a recent study in women with severe pre-existing cardiovascular diseases during Caesarean section under general anaesthesia. 19 In this study, fluid administration was performed very carefully under close monitoring of ITBV and EVLW. The transpulmonary indicator dilution method to assess EVLW closely correlates with the gravimetric method, which is the gold standard to determine lung water content. 14 20 It has been validated both in animals 8 and in patients, 7 13 21 and is being routinely used for cardiopulmonary monitoring of critically ill patients at the bedside in the ICU and during surgery. 22 Normal values for ITBV have been proposed to be 850-1000 ml m 22 body surface area and ,7 ml kg 21 body weight for EVLW. 11 -13 In addition, the EVLW/ITBV ratio has been used as a measure of microvascular pulmonary permeability, 11 12 14 the normal ratio of which is between 0.2 and 0.3. 11 -13 The rationale of using the EVLW/ITBV ratio as a measure of pulmonary microvascular permeability is based on the fact that EVLW may be increased by an abnormal vascular permeability or an increase in hydrostatic pressure. Since the increase in EVLW in hydrostatic pulmonary oedema is due to an increase in pulmonary blood volume and pressure, the EVLW/ITBV ratio should be much lower than in permeability oedema.
In the present study, pulmonary gas exchange was normal during and after the fetoscopic interventions. However, EVLW was above the normal range, despite a restrictive infusion protocol which aimed at a relatively low ITBV which has been shown to be an accurate surrogate parameter of intravascular filling even during mechanical ventilation. 23 24 Calculations of pulmonary vascular permeabiltity as the ratio of EVLW to ITBV resulted in values being moderately increased in our patients. In addition, linear regression analysis did not show any significant correlation between systemic blood flow, mean pulmonary arterial pressure, pulmonary arterial occlusion pressure, ITBV, and EVLW. These results may indicate that hydrostatic mechanisms were unlikely to cause the slight increase in EVLW in our patients. 25 In conclusion, the moderate increases in lung water content and pulmonary vascular permeability confirm the clinical observation that pregnant women are prone to accumulate relevant amounts of water in the lung interstitium. However, percutaneous fetoscopic interventions under general anaesthesia can be performed safely for mothers as concerns cardiopulmonary function. In technically difficult and long-lasting procedures, the transpulmonary indicator dilution method provides valuable information of the maternal cardiovascular status and lung water content which can be used to balance fluid therapy, intra-amnial fluid administration, and vasoactive medication.
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